PF-05241328

DB15124InvestigationalSmall molecule

PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound...

Formula / weight: C₁₉H₂₁ClN₄O₄S · 436.91 g/mol (avg)
Code names: PF-05241328

Resolves to

Compound

UNII8RAL5N48VTCAS1387633-03-5

Structure

InChIKeyRVTSXVZXEGFIPW-UHFFFAOYSA-NSMILESCC(C)COC1=NC=C(C=C1Cl)N1N=C(C)C2=C1C=CC(=C2)C(=O)NS(C)(=O)=O

Targets

Q15858SCN9A

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-05241328, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account